Renal cell carcinoma treated by vaccines for active specific immunotherapy: Correlation of survival with skin testing by autologous tumor cells-Reference-Cited by-同舟云学术

Renal cell carcinoma treated by vaccines for active specific immunotherapy: Correlation of survival with skin testing by autologous tumor cells

Published:1990-01 Issue:1 Volume:32 Page:62-66
ISSN:0340-7004
Container-title:Cancer Immunology Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

McCune Craig S.,O'Donnell Robert W.,Marquis Diana M.,Sahasrabudhe Deepak M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF01741726.pdf

Reference12 articles.

1. Askenase PW, Hayden BJ, Gershon RK (1975) Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J Exp Med 141: 697

2. Berd D, Mastrangelo MJ, Engstrom PF, Paul A, Maguire H (1982) Augmentation of the human immune response by cyclophosphamide. Cancer Res 42: 4862

3. Berd D, Maguire HC, Mastrangelo MJ (1986) Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide. Cancer Res 46: 2572

4. Burdick JF, Wells Jr SA, Herberman RB (1975) Collective review: immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. Surg Gynecol Obstet 141: 779

5. Hoover HC, Surdyke MG, Dangel RB, Peters LC, Hanna MG (1984) Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: bacillus Calmette-Guérin vaccine. Cancer Res 44: 1671

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting MSS colorectal cancer with immunotherapy: are we turning the corner?;Expert Opinion on Biological Therapy;2021-05-31

2. Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial;Cancer Immunology, Immunotherapy;2019-03-09

3. Cancer Immunotherapy with Vaccines and Checkpoint Blockade;The Molecular Basis of Cancer;2015

4. Role of vaccine therapy for renal cell carcinoma in the era of targeted therapy;International Journal of Urology;2013-03-21

5. Cellular immunotherapy (CI), where have we been and where are we going?;Principles of Cancer Biotherapy;2009